Back in April, I wrote the piece 5 Apps Leveraging Apple’s ResearchKit For Clinical Studies. What’s interesting, in retrospect, is that none of those apps were developed by pharmaceutical companies, but rather by academic medical centers and nonprofit organizations.
Posts Tagged ‘clinical trials’
Perficient Receives Award From Oracle Health Sciences
< The work we’re doing for life sciences and healthcare companies continues to pay off. And, Oracle thinks so, too. We recently received an award from Oracle’s Health Sciences Global Business Unit for the work we’re doing with their clinical and pharmacovigilance applications.
Risk-Based Monitoring, In Layman’s Terms
One of my LinkedIn contacts shared the video Risk-Based Monitoring vs Remote Monitoring Finally Explained, in which Dan Sfera of www.theclinicaltrialsguru.com explains both concepts in layman’s terms. In essence, the idea of Risk-Based Monitoring (RBM) is to leverage the data in existing IT systems to spot, rectify, and prevent issues relating to the execution of […]
Who Should Notify The FDA About Using Esigs: CRO Or Sponsor?
Several months ago we delivered a webinar on 21 CFR Part 11, based on a recent blog series. During the Q&A session at the end, someone asked the following question: Regarding “the organization” that needs to inform the FDA of the intended use of electronic signatures, in a CRO/Sponsor relationship, who is responsible: the […]
Are Email Attachments Subject To 21 CFR Part 11?
On Thursday, April 23, 2015, we delivered a webinar on 21 CFR Part 11, based on a recent blog series. During the Q&A session at the end, someone asked the following question: In one of the initial slides, you mentioned that documents attached to emails do not fall under 21 CFR Part 11. Could […]
Eli Lilly Is Doing Something Interesting, Digitally Speaking
On June, 28, 2015, CNN will be presenting Glen Campbell: I’ll Be Me, a documentary that showcases the life of the award-winning musician who struggles with Alzheimer’s. What’s unique about the film’s presentation, aside from the story itself, is that it will be complemented with three targeted commercials: a 30-second commercial, in which Eli […]
Clinical Trials And Teddy Bears
If you have children, you know what it like is to give them a shot or any other type of medication. You also know what’s it’s like to take them to the doctor and have a “stranger” give them a simple checkup, let alone convince them to comply with more intrusive requests. That’s why […]
Top 5 Life Sciences Blog Posts From May 2015
Now that June is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in May – they’re ranked in order of popularity, with number one being the most viewed piece.
Can We Integrate Clinical And Safety Systems In The Cloud?
In our last “cloud fact or fiction” post, we discussed the ability to migrate clinical and pharmacovigilance data to the cloud. Let’s jump right in and talk about system integrations in the cloud. Claim #7: Clinical trial software in the cloud cannot be integrated with other systems.
Companion Diagnostics and Pharmaceuticals: Tying The Knot
I recently read an article, The Future of Cancer Treatment Is (Almost) Here, which discusses liquid biopsy, a method of using blood samples to detect cancer. While new forms of cancer detection and monitoring continue to be developed, we’ve already made significant strides in the treatment of certain diseases.
Study Managers, Siebel CTMS Puts It All At Your Fingertips
It’s no secret that having a clinical trial management system (CTMS) streamlines and simplifies the running of clinical trials, and that Oracle’s Siebel Clinical (Siebel CTMS) is the most robust system in the space. But, as a Study Manager, what you might not know is exactly how it would make YOUR work life easier. […]
Using Skype For Informed Consent In Clinical Trials?
Getting informed consent from patients is one of the most critical aspects of a clinical trial. The objective is simple: provide patients with information about the study plan (doctor visits, tests, etc.) and risks/benefits, make sure they understand the information, and get their (legally effective) consent to participate. The faster this is done, the […]